Sodium Picosulphate/Magnesium Citrate and Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy

• Status: Completed
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Adequate bowel cleansing is essential for effective colonoscopy. Acceptance of colon preparation affects the quality of colon cleansing. The study is aimed at comparing the efficacy, safety and acceptability of sodium picosulphate/magnesium citrate (PMC) and low-volume PEG -ascorbic acid (PEG+ASC)in colon cleansing, and to identify predictors of poor bowel preparation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: ASST Fatebenefratelli Sacco; Ospedale L. Sacco – Polo Universitario
• Treatments: Ascorbic Acid; Citric Acid; Magnesium citrate; Picosulfate sodium

Criteria

Inclusion Criteria:

• adult outpatients

• aged 18-85 years

• undergoing elective colonoscopy

Exclusion Criteria:

• previous colon resection

• ileus

• intestinal obstruction

• toxic megacolon

• severe heart failure (New York Heart Association [NYHA] Class III or IV)

• acute cardiovascular disease

• uncontrolled arterial hypertension (systolic pressure > 170 mmHg, diastolic pressure > 100 mmHg)

• severe liver failure or ascites

• end-stage renal failure

• phenylketonuria

• glucose-6-phosphate dehydrogenase deficiency. Women were excluded from the study if they were pregnant, breastfeeding